What is NIMGenetics?
Headquartered in Spain, NIMGenetics operates as a specialized biomedical entity focused on the delivery of advanced clinical genetics. The firm provides a comprehensive suite of diagnostic solutions tailored for healthcare professionals across diverse medical disciplines, including oncology, neurology, pediatrics, and gynecology. By integrating personalized genetic analysis with robust clinical support, NIMGenetics aims to improve patient outcomes and quality of life for those affected by genetic disorders. The company maintains a significant international footprint, with active service delivery models spanning Spain, Portugal, Mexico, and the United States, positioning it as a key player in the global diagnostic infrastructure.
How much funding has NIMGenetics raised?
NIMGenetics has raised a total of $7.6M across 1 funding round:
Private Equity
$7.6M
Private Equity (2017): $7.6M with participation from Apposite Capital
Key Investors in NIMGenetics
Apposite Capital
Apposite Capital is a private equity firm specializing in the healthcare industry, focusing on lower mid-market investments across Europe. They support healthcare SMEs through management buyouts, growth capital, and strategic guidance to drive substantial growth and positive health impact.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for NIMGenetics?
With the infusion of capital, NIMGenetics is well-positioned to accelerate its enterprise-level growth strategy. The company is expected to focus on expanding its diagnostic portfolio and enhancing its technological capabilities to meet the rising demand for personalized healthcare. Future initiatives will likely involve deepening its market penetration in the United States and Mexico, while simultaneously optimizing its laboratory infrastructure to maintain high standards of accuracy and efficiency. As the firm scales, it remains focused on fostering innovation in genetic diagnostics, ensuring that healthcare providers have access to the most reliable data to inform critical clinical decisions.
See full NIMGenetics company page
